STREAMLINING HEALTHCARE BLOG

Archive for Policy Outlook & Analysis

USTR Releases List Of Chinese Imports Subject To Tariffs

USTR Releases List Of Chinese Imports Subject To Tariffs

On June 15, the United States Trade Representative (USTR) identified $50 billion in Chinese imports that will be subject to a 25% tariff. The agency has published two lists of products affected by the tariff. The first list contains $34 billion worth of Chinese goods and will take effect July 6, 2018. The second list [...]

Continue Reading →

Posted in: Advocacy and Gov Affairs, HIDA News, Policy Outlook & Analysis, Research & Analysis

Leave a Comment (0) →

Lab Providers Have Opportunities Despite Reimbursement Cuts

Lab Providers Have Opportunities Despite Reimbursement Cuts

You’ve likely heard about the Medicare payment cuts lab providers are experiencing as part of the Protecting Access to Medicare Act of 2014 (PAMA). These cuts are much deeper than initially projected – lowering payments by $670 million, instead of the expected $390 million. While these cuts are significant, many experts believe this sector is [...]

Continue Reading →

Posted in: Conference news & updates, Cost Management, Policy Outlook & Analysis

Leave a Comment (0) →

Physician Offices See Uptick In Flu Vaccinations

Physician Offices See Uptick In Flu Vaccinations

Over 37% of adults and 65.3% of children received influenza vaccines at physician offices during the 2016-17 flu season, up from 33% and 63.7% the previous year, respectively, according to the Centers for Disease Control and Prevention. Outside of this setting, adults typically received their flu shot at their workplace or at drug stores, while [...]

Continue Reading →

Posted in: Advocacy and Gov Affairs, HIDA Resources, Policy Outlook & Analysis, Research & Analysis

Leave a Comment (0) →

Insights for the 2016 Flu Season

Insights for the 2016 Flu Season

The Centers for Disease Control and Prevention (CDC) released its annual update on seasonal influenza and vaccine recommendations for the 2016-17 flu season. Notably, the CDC has recommended against the FluMist nasal spray vaccine due to questions over its effectiveness. The CDC’s recommendation has not affected the FDA’s approval of the vaccine. Just in time [...]

Continue Reading →

Posted in: AMS Webinars & Training, Efficient Access, HIDA Resources, Patient Care Focus, Policy Outlook & Analysis, Supply chain data trends

Leave a Comment (0) →

Distributors Advocate for Supply Chain on Capitol Hill

Distributors Advocate for Supply Chain on Capitol Hill

Every year, HIDA members converge in Washington, D.C., for the annual Washington Summit. This event allows supply chain executives to hold meetings with members of Congress and key staffers, advocating for healthcare policy initiatives most important to providers and suppliers alike. Each year’s event builds off of the success of the prior year’s efforts, and [...]

Continue Reading →

Posted in: Advocacy and Gov Affairs, Conference news & updates, HIDA News, How distributors make a difference, Policy Outlook & Analysis

Leave a Comment (0) →

Influencing Key Supply Chain Issues on Capitol Hill

Influencing Key Supply Chain Issues on Capitol Hill

More than 60 healthcare supply chain leaders recently met in Washington, D.C., to participate in HIDA’s Healthcare Distribution Summit. The event featured strategic, topical discussions from speakers instrumental in shaping healthcare policy decisions. HIDA hosted a Lobbying Fly-in prior to the Summit with 40 member executives holding 62 meetings on Capitol Hill with Members of [...]

Continue Reading →

Posted in: Advocacy and Gov Affairs, Conference news & updates, HIDA News, How distributors make a difference, Member Spotlights, Policy Outlook & Analysis

Leave a Comment (0) →

The Reimbursement Shifts Affecting Your Bottom Line

The Reimbursement Shifts Affecting Your Bottom Line

This week, the President signed into law Congressional legislation to avoid a 24% cut in physician Medicare reimbursement. However, doing another short term “patch” furthered delay efforts to repeal and replace the physician sustainable growth rate (SGR) formula, which determines physician payment rates. HIDA’s Government Affairs team published a follow-up Policy Outlook summary, explaining which [...]

Continue Reading →

Posted in: Advocacy and Gov Affairs, AMS Webinars & Training, Healthcare reform trends & impact, Medicaid/Medicaid, Policy Outlook & Analysis, Special Features

Leave a Comment (0) →

Targeted Advocacy Enhances Patient Safety and Supply Chain Integrity

Targeted Advocacy Enhances Patient Safety and Supply Chain Integrity

Our industry celebrated a major victory in 2013 when, after years of advocacy efforts, national pedigree legislation was signed into law. This is great news for providers because it allows manufacturers and distributors to conduct business more effectively and efficiently across all 50 states, enhancing patient safety and supply chain integrity. Providers and suppliers alike [...]

Continue Reading →

Posted in: Advocacy and Gov Affairs, HIDA News, How distributors make a difference, Policy Outlook & Analysis, Special Features

Leave a Comment (0) →
Page 1 of 2 12